The Osteopathic Research Center is the premier research center focusing on the clinical efficacy and mechanisms of action of osteopathic manipulative treatment (OMT). The ORC also conducts health services and policy research by performing systematic reviews of the literature, conducting population based surveys, and analyzing national health care databases to determine the unique practice characteristics of osteopathic physicians and to provide scientific evidence to support osteopathic medicine.
The ORC operates a fast-paced clinical research enterprise with numerous NIH-funded studies, including the OSTEOPAThic Health outcomes In Chronic low back pain Trial (OSTEOPATHIC Trial), which is projected to be the largest clinical trial involving OMT. Cutting-edge basic science research is assessing the response to OMT techniques, such as lymphatic pump, at the molecular and cellular level. The ORC's health services and policy research is providing the evidence to develop clinical practice guidelines for OMT in conditions such as low back pain.
Faculty at the ORC have been recognized for their research accomplishments through national awards, invitations to present at national and international conferences, and by serving in consultative roles with such organizations as the World Health Organization.
- The ORC is recruiting osteopathic physicians to conduct clinical research as members of the CONCORD-PBRN. If you or a colleague are interested in working with us to advance the research agenda of the profession, please contact John C. Licciardone, DO, MS, MBA, executive director.
- Do you have Type 2 diabetes and chronic low back pain? You may be eligible to participate in a study being conducted at the University of North Texas Health Science Center in Fort Worth. To learn more, call 817-735-2114.
- Congratulations to John C. Licciardone, DO, MS, MBA, for being named an Unsung Hero of the osteopathic profession by the American Osteopathic Association
- Follow us on Twitter @ORCresearch
- Like us on FaceBook
More News ...